BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Clinical trial NCT07226856 · RECRUITING

Trial details

NCT number: NCT07226856
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Recurrent Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2025-12-12
Primary completion: 2028-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.